Chargement en cours...
Effect of the oral endothelin antagonist bosentan on the clinical, exercise, and haemodynamic status of patients with pulmonary arterial hypertension related to congenital heart disease
Objective: To evaluate the clinical, exercise, and haemodynamic effects of chronic oral administration of the non-selective endothelin receptor antagonist bosentan on patients with pulmonary arterial hypertension (PAH) related to congenital heart disease (CHD). Design: Prospective non-randomised ope...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Format: | Artigo |
| Langue: | Inglês |
| Publié: |
Copyright 2005 by Heart
2005
|
| Sujets: | |
| Accès en ligne: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1769173/ https://ncbi.nlm.nih.gov/pubmed/15761050 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/hrt.2004.051961 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|